Oscar Health Inc (OSCR)
🔔 Watch stock
Appears in These Scanners
This stock currently matches 32 of our scanner strategies — each hit links to the scanner.
Only genuine hits from verified scanners count; pure ranking metrics (P/E, P/S, and similar, which just sort the whole universe) don't count as a hit. View all scanners
Basics
Performance
Valuation
Profitability
Balance Sheet & Safety
Growth
Quality & Screener
AI Rating
Uses AIOscar Health nutzt KI operativ und breit im eigenen Technologie-Stack: Laut Geschäftsbericht (10-K) für 2025 sind KI-Technologien in Automatisierung (virtuelle Versorgung, Abrechnungsverarbeitung), Mitglieder-Personalisierung und digitale Self-Service-Funktionen eingebettet; 2025 startete zudem der persönliche KI-Agent „Oswell“ für Mitglieder. Eine KI-Umsatzquelle ist nicht dokumentiert (die +Oscar-Plattformerlöse sind unwesentlich), und die Risikofaktoren behandeln nur Risiken aus der eigenen KI-Nutzung — daher „Nutzt KI“.
View the full file — quotes, sources, reviewed filings
„We have embedded AI Technologies across many aspects of our technology stack, including: (i) automation to drive efficiencies in our administrative functions, including virtual care and claims processing, (ii) member personalization, to improve the quality of touchpoints members have with the healthcare ecosystem; and (iii) digital self-service and member-facing agent capabilities to facilitate care and improve the member experience."
Wir haben KI-Technologien in viele Bereiche unseres Technologie-Stacks eingebettet, darunter: (i) Automatisierung, um Effizienzgewinne in unseren Verwaltungsfunktionen zu erzielen, einschließlich virtueller Versorgung und Abrechnungsverarbeitung, (ii) Mitglieder-Personalisierung, um die Qualität der Berührungspunkte der Mitglieder mit dem Gesundheitssystem zu verbessern, und (iii) digitale Self-Service- und mitgliederorientierte Agenten-Funktionen, um die Versorgung zu erleichtern und das Mitgliedererlebnis zu verbessern.
„Our business currently utilizes AI Technologies to drive efficiencies in our business, including by deploying use cases that are designed to streamline administrative processes, improve the experience for our members and providers and enhance our decision making capabilities. We are making, and plan to make in the future, investments in adopting AI Technologies across our business and across our technology stack. For example, in 2025, we launched Oswell, a personal AI agent designed to provide our members with on-demand support and doctors with data to improve care paths."
Unser Geschäft nutzt KI-Technologien derzeit, um Effizienzgewinne zu erzielen — unter anderem mit Anwendungsfällen, die Verwaltungsprozesse verschlanken, das Erlebnis für unsere Mitglieder und Leistungserbringer verbessern und unsere Entscheidungsfähigkeit stärken sollen. Wir investieren — und planen auch künftig zu investieren — in die Einführung von KI-Technologien in unserem gesamten Geschäft und Technologie-Stack. So haben wir 2025 Oswell gestartet, einen persönlichen KI-Agenten, der unseren Mitgliedern Unterstützung auf Abruf bietet und Ärzten Daten zur Verbesserung der Behandlungspfade liefert.
„Leveraging AI enabled member and provider service touch points to provide high quality, impactful services at scale, including chatbots to answer health, wellness and insurance plan questions."
Nutzung KI-gestützter Service-Kontaktpunkte für Mitglieder und Leistungserbringer, um hochwertige, wirkungsvolle Dienste in großem Maßstab zu erbringen — einschließlich Chatbots, die Fragen zu Gesundheit, Wohlbefinden und Versicherungsplänen beantworten.
Filings Reviewed: 10-Q 2026-05-07 · 10-Q 2025-11-06 · 10-Q 2025-08-07 · 10-Q 2025-05-08 · 10-K 2026-02-13 · 10-K 2025-02-20
Rated on July 9, 2026 · How the Rating Is Built
Highlighted are things our editorial team noticed: green = stands out as strong, red = deserves a closer look. No single metric is a verdict on its own — always read it in context.
Quarterly Figures
| Quarter | EPS (Earnings Per Share) | EPS YoY (%) | Sales ($M) | Sales YoY (%) | Net Margin (%) | OCF ($M) | FCF ($M) |
|---|---|---|---|---|---|---|---|
| 2024: Q4 | -0.58 | – | 2,392 | 67.10 | -6.40 | 347 | 340 |
| 2025: Q1 | 0.90 | 49.00 | 3,046 | 42.20 | 9.00 | 879 | 870 |
| 2025: Q2 | -0.85 | -557.00 | 2,864 | 29.00 | -8.00 | 509 | 500 |
| 2025: Q3 | -0.53 | – | 2,986 | 23.20 | -4.60 | -965 | -974 |
| 2025: Q4 | -1.24 | – | 2,805 | 17.30 | -12.60 | 672 | 663 |
| 2026: Q1 | 2.06 | 128.90 | 4,647 | 52.60 | 14.60 | 2,619 | 2,610 |
- EPS (Earnings Per Share):
- Quarterly profit divided by the total share count — how much of the profit works out to a single share.
- YoY (Year over Year):
- Change versus the same quarter a year ago — this is how you compare without seasonal distortion (e.g. the holiday shopping season).
- Sales:
- All revenue for the quarter, before any costs are deducted — the top line of the income statement.
- Net Margin:
- What percentage of sales is left over as profit in the end. Negative means the company is posting a loss.
- OCF (Operating Cash Flow):
- The cash that actually flows into the till from the core business during the quarter — harder to dress up than book profit.
- FCF (Free Cash Flow):
- Operating cash flow minus capital expenditures — the money that's genuinely free to use, say for paying down debt, buybacks, or dividends.
About the Company
Oscar Health, Inc. ist als Gesundheitstechnologieunternehmen in den USA tätig.
| Employees | 2,305 |
|---|---|
| Headquarters | New York, NY |
| Website | hioscar.com |
| IPO Date | 3. Mar 2021 |
| Next Earnings | 5. Aug 2026 |
Management
| Name | Title | Birth Year |
|---|---|---|
| Mark Thomas Bertolini | CEO & Director | 1957 |
| Joshua Kushner | Co-Founder & Vice Chairman | 1985 |
| Mario Tobias Schlosser | Co-Founder, Advisor to the CEO & Director | 1979 |
| Adam McAnaney | EVP & Chief Legal Officer | 1977 |
| Janet Ann Liang | EVP & President of Oscar Insurance | 1968 |
| Victoria Baltrus | Chief Accounting Officer | 1970 |
| Chris Potochar | Vice President of Treasury & Investor Relations | – |
| Rebecca Krouse | Chief People Officer | – |
| Joel I. Klein J.D. | Senior Advisor | 1947 |
| Chelsea Cooper | Chief Growth Officer of +Oscar | – |
Executives per the latest required filings; titles kept in their original language. Source: fundamental data.
Chart
Interactive price chart (TradingView).
Data as of: July 20, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.